Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
15 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
15 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
15 Feb 22
Current reports
8-K
Results of Operations and Financial Condition
15 Feb 24
8-K
Other Events
6 Feb 24
8-K
ROYALTY PHARMA HIGHLIGHTS ACCOMPLISHMENTS AND PROVIDES BUSINESS UPDATE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
8 Jan 24
8-K
Entry into a Material Definitive Agreement
27 Dec 23
8-K
Other Events
27 Dec 23
8-K
Other Events
16 Nov 23
8-K
Results of Operations and Financial Condition
8 Nov 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
19 Oct 23
8-K
Results of Operations and Financial Condition
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
23 Jun 23
Registration and prospectus
424B3
Prospectus supplement
16 Nov 23
424B3
Prospectus supplement
15 Apr 22
424B5
Prospectus supplement for primary offering
19 Jul 21
FWP
Free writing prospectus
15 Jul 21
424B5
Prospectus supplement for primary offering
15 Jul 21
S-3ASR
Automatic shelf registration
14 Jul 21
424B3
Prospectus supplement
7 Jul 21
S-4
Registration of securities issued in business combination transactions
18 Jun 21
424B4
Prospectus supplement with pricing info
19 Oct 20
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
Other
UPLOAD
Letter from SEC
30 Jan 24
CORRESP
Correspondence with SEC
24 Jan 24
CORRESP
Correspondence with SEC
11 Dec 23
UPLOAD
Letter from SEC
27 Nov 23
EFFECT
Notice of effectiveness
8 Jul 21
CORRESP
Correspondence with SEC
1 Jul 21
UPLOAD
Letter from SEC
25 Jun 21
EFFECT
Notice of effectiveness
16 Oct 20
CORRESP
Correspondence with SEC
13 Oct 20
CORRESP
Correspondence with SEC
13 Oct 20
Ownership
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
4
Henry A Fernandez
2 Apr 24
4
Bonnie L Bassler
2 Apr 24
144
Notice of proposed sale of securities
28 Feb 24
4
RORY B RIGGS
22 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
GENERAL ATLANTIC, L.P.
13 Feb 24
SC 13G/A
MORGAN STANLEY
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24